Your browser doesn't support javascript.
loading
Operational lessons learned in conducting a multi-country collaboration for vaccine safety signal verification and hypothesis testing: The global vaccine safety multi country collaboration initiative.
Guillard-Maure, Christine; Elango, Varalakshmi; Black, Steven; Perez-Vilar, Silvia; Castro, Jose Luis; Bravo-Alcántara, Pamela; Molina-León, Helvert Felipe; Weibel, Daniel; Sturkenboom, Miriam; Zuber, Patrick L F.
Afiliación
  • Guillard-Maure C; Department of Essential Medicines and Health Products, World Health Organization, Geneva, Switzerland. Electronic address: maurec@who.int.
  • Elango V; International Professional Consultant, World Health Organization, Geneva, Switzerland.
  • Black S; Center for Global Child Health, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States; VACCINE.GRID Foundation, Basel, Switzerland.
  • Perez-Vilar S; Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands; Vaccine Research Unit, Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana, FISABIO, Valencia, Spain.
  • Castro JL; Unit of Medicines and Health Technologies, Department of Health Systems and Services, Pan American Health Organization (PAHO/WHO), Washington DC, DC, United States.
  • Bravo-Alcántara P; Unit of Comprehensive Family Immunization, Department of Family, Gender and Life Course, Pan American Health Organization (PAHO/WHO), Washington DC, DC, United States.
  • Molina-León HF; International Professional Consultant, Pan American Health Organization (PAHO/WHO), Washington DC, DC, United States.
  • Weibel D; VACCINE.GRID Foundation, Basel, Switzerland; Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Sturkenboom M; VACCINE.GRID Foundation, Basel, Switzerland; Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands; Utrecht University Medical Center, Julius Global Health, The Netherlands.
  • Zuber PLF; Department of Essential Medicines and Health Products, World Health Organization, Geneva, Switzerland.
Vaccine ; 36(3): 355-362, 2018 01 08.
Article en En | MEDLINE | ID: mdl-28780118
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vigilancia de Productos Comercializados / Vacunas / Cooperación Internacional Tipo de estudio: Screening_studies Límite: Female / Humans / Infant / Male Idioma: En Revista: Vaccine Año: 2018 Tipo del documento: Article Pais de publicación: Países Bajos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vigilancia de Productos Comercializados / Vacunas / Cooperación Internacional Tipo de estudio: Screening_studies Límite: Female / Humans / Infant / Male Idioma: En Revista: Vaccine Año: 2018 Tipo del documento: Article Pais de publicación: Países Bajos